The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center
暂无分享,去创建一个
M. Valeanu | C. Faur | H. Rotar | R. Roman | Laura Filip | M. Moldovan
[1] F. Bassetto,et al. Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review , 2021, Frontiers in Oncology.
[2] K. Sultanem,et al. Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review , 2021, Journal of Otolaryngology - Head & Neck Surgery.
[3] M. Koziej,et al. Detailed head localization and incidence of skin cancers , 2021, Scientific Reports.
[4] T. Hanna,et al. Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study , 2021, PloS one.
[5] M. Błasińska-Morawiec,et al. The incidence and clinical analysis of non-melanoma skin cancer , 2021, Scientific Reports.
[6] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[7] J. Califano,et al. An Analysis of 1-Year Charges for Head and Neck Cancer: Targets for Value-Based Interventions , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[8] E. Kasumagić-Halilović,et al. A Clinical Study of Basal Cell Carcinoma , 2019, Medical archives.
[9] Samuel J. Lin,et al. Regional incidence of and reconstructive management patterns in melanoma and nonmelanoma skin cancer of the head and neck: A 3-year analysis in the inpatient setting. , 2019, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[10] V. Kähäri,et al. Complement System in Cutaneous Squamous Cell Carcinoma , 2019, International journal of molecular sciences.
[11] J. Shah,et al. Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications , 2019, Current Oncology Reports.
[12] S. Sarker,et al. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data. , 2019, Current oncology.
[13] E. Adjei Boakye,et al. Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors , 2019, JAMA otolaryngology-- head & neck surgery.
[14] B. Murthy,et al. A review of ASA physical status – historical perspectives and modern developments , 2019, Anaesthesia.
[15] A. Costa-Pereira,et al. Skin cancer healthcare impact: A nation-wide assessment of an administrative database. , 2018, Cancer epidemiology.
[16] P. Demers,et al. The economic burden of occupational non-melanoma skin cancer due to solar radiation , 2018, Journal of occupational and environmental hygiene.
[17] P. Romano,et al. Hospitalization Rates and Predictors of Rehospitalization Among Individuals With Advanced Cancer in the Year After Diagnosis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] V. Rao,et al. The Economics of Skin Cancer: An Analysis of Medicare Payment Data , 2016, Plastic and reconstructive surgery. Global open.
[19] S. Whitaker,et al. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.
[20] Grey Giddins,et al. Statistics , 2016, The Journal of hand surgery, European volume.
[21] M. Crane,et al. Estimating the economic costs of skin cancer in New South Wales, Australia , 2015, BMC Public Health.
[22] A. Marzuka,et al. Basal Cell Carcinoma: Pathogenesis, Epidemiology, Clinical Features, Diagnosis, Histopathology, and Management , 2015, The Yale journal of biology and medicine.
[23] K.,et al. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. , 2015, American journal of preventive medicine.
[24] L. Iancu,et al. Epidemiological and pathological aspects of skin cancer in North East of Romania. , 2014, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.
[25] C. Reyes,et al. Age distribution of patients with advanced non-melanoma skin cancer in the United States , 2013, Archives of Dermatological Research.
[26] W. Hwang,et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. , 2013, JAMA dermatology.
[27] J. Leonardi-Bee,et al. A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.
[28] Eric J Feuer,et al. Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.
[29] S. Dalton,et al. Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark. , 2010, Cancer epidemiology.
[30] David Howard,et al. Cancer treatment cost in the United States , 2010, Cancer.
[31] Corwin M Zigler,et al. Analysis of national skin cancer expenditures in the United States Medicare population, 2013 , 2019, Journal of the American Academy of Dermatology.
[32] M. Iglesias,et al. Oncologic surgery of the eyelid and orbital region. , 2015, Actas dermo-sifiliograficas.
[33] S. Çelebi̇oğlu,et al. Reconstruction of periorbital region defects: A retrospective study , 2014, Annals of maxillofacial surgery.
[34] Martin A Weinstock,et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. , 2014, The Journal of investigative dermatology.
[35] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.